Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.7785
+0.0660 (9.26%)
At close: Nov 14, 2025, 4:00 PM EST
0.7800
+0.0015 (0.19%)
Pre-market: Nov 17, 2025, 8:38 AM EST
Immunic Stock Forecast
Stock Price Forecast
The 4 analysts that cover Immunic stock have a consensus rating of "Strong Buy" and an average price target of $6.00, which forecasts a 670.71% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $8.00.
Price Target: $6.00 (+670.71%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immunic stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 3 | 3 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +927.62% | Nov 14, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +927.62% | Nov 13, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +285.36% | Sep 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,184.52% | Sep 26, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,184.52% | Sep 25, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
17.00M
EPS This Year
-0.75
from -1.00
EPS Next Year
-0.47
from -0.75
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 105.0M | |||
| Avg | n/a | 17.0M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.56 | -0.05 | |||
| Avg | -0.75 | -0.47 | |||
| Low | -0.89 | -0.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.